[On the anti-arrhythmia activity of a new adrenergic blocking agent].
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001281:Atrial Fibrillation / Q000188:drug therapy; D001919:Bradycardia / Q000139:chemically induced; D004071:Digitalis Glycosides / Q000494:pharmacology; D004176:Dipyridamole / Q000378:metabolism*; D004357:Drug Synergism; D004837:Epinephrine / Q000009:adverse effects; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D013565:Sympatholytics / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy
D004071:Digitalis Glycosides; D013565:Sympatholytics; D004176:Dipyridamole; D004837:Epinephrine
Sur l'activité anti-arythmique d'un nouvel agent de blocage beta-adrénergique.